- Home
- XNCR vs NWBI Comparison
XNCR vs NWBI Comparison
Compare XNCR & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | NWBI |
|---|---|---|
| Founded | 1997 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2013 | 2009 |
Fundamental Metrics
Financial Performance| Metric | XNCR | NWBI |
|---|---|---|
| Price | $29.82 | $15.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 8 |
| Target Price | ★ $41.58 | $16.43 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 11-13-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 5.21% |
| EPS Growth | ★ 65.36 | 16.46 |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | $18.52 | $11.49 |
| Revenue Next Year | N/A | $4.84 |
| P/E Ratio | ★ N/A | $21.56 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $10.38 | $11.25 |
| 52 Week High | $33.60 | $16.16 |
Technical Indicators
Market Signals| Indicator | XNCR | NWBI |
|---|---|---|
| Relative Strength Index (RSI) | 65.50 | 52.59 |
| Support Level | $22.80 | $15.17 |
| Resistance Level | $30.61 | $15.71 |
| Average True Range (ATR) | 1.71 | 0.30 |
| MACD | 0.59 | 0.05 |
| Stochastic Oscillator | 61.74 | 55.19 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.